Allan C Collins | OMICS International
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Allan C Collins

Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado, USA


Professor Collins received his Ph.D. in Pharmacology from the University of Wisconsin in 1969, after which he did an NIH Postdoctoral Fellowship at the University of Colorado Medical School. He joined the faculty of the University of Colorado in 1972 and is now a Professor of Pharmacology with the School of Pharmacy and the School of Medicine and a Professor of Psychology in the Department of Psychology. He is a member of several scientific societies, including The Society for Research on Nicotine and Tobacco for which he has served on the Board of Directors. To date he has authored or co-authored 233 scientific articles and 236 scientific abstracts.
Research Interest
Currently Dr. Collins' research focuses on identifying neurochemical systems that play a role in regulating behavioral responses to drugs of abuse, particularly nicotine and alcohol. Because studies with humans indicate that genetic factors regulate addiction to both nicotine and alcohol, Dr. Collins' lab has used genetic strategies to identify neurochemical systems that regulate nicotine and alcohol actions. The long-term goal of his work is to develop drugs that modify critical "addiction-related" system